Paper Details

  1. Home
  2. Paper Details

Nebulized albuterol in acute bronchiolitis.

Author: BenturL, CannyG, KeremE, LevisonH, PetricM, ReismanJ J, SchuhS

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Nebulized albuterol was found to be a safe and effective treatment for infants with bronchiolitis, significantly improving accessory muscle score, oxygen saturation, and respiratory rate.
Paper Details　
Original Abstract of the Article :
In a double-blind, placebo-controlled trial, 40 infants between 6 weeks and 24 months of age who had a first episode of wheezing and other signs and symptoms of bronchiolitis were randomly assigned to receive either nebulized albuterol (0.15 mg/kg/dose) or placebo (saline solution) for two administr...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/s0022-3476(05)80706-1

データ提供：米国国立医学図書館（NLM）

Nebulized Albuterol: A Safe and Effective Treatment for Bronchiolitis

In the field of [Pediatrics], finding effective and safe treatments for bronchiolitis, a common respiratory infection in infants, is a priority. This double-blind, placebo-controlled trial investigates the efficacy of nebulized albuterol in treating bronchiolitis. The researchers aim to evaluate the effectiveness of albuterol in improving symptoms and reducing the severity of bronchiolitis in infants.

Nebulized Albuterol: A Safe and Effective Treatment for Bronchiolitis

This study involved 40 infants with bronchiolitis who were randomly assigned to receive either nebulized albuterol or placebo. The researchers found that albuterol significantly improved symptoms, including accessory muscle use, oxygen saturation, respiratory rate, and heart rate. These findings suggest that nebulized albuterol could be a safe and effective treatment option for bronchiolitis in infants.

A Breath of Fresh Air for Infants with Bronchiolitis

Imagine a baby struggling to breathe, like a small camel caught in a sandstorm. Nebulized albuterol, like a cool breeze, can help open up the airways and provide relief from the symptoms of bronchiolitis. This study provides encouraging evidence for the use of albuterol in treating this common respiratory infection in infants.

Dr. Camel's Conclusion

This study demonstrates the safety and effectiveness of nebulized albuterol in treating bronchiolitis. It offers a valuable treatment option for infants struggling with this common respiratory infection, providing relief from symptoms and promoting faster recovery. Just as a camel can adapt to the harsh desert climate, we can use medication like albuterol to help infants navigate the challenges of bronchiolitis and breathe easier.

Date :
  1. Date Completed 1990-11-05
  2. Date Revised 2019-06-30
Further Info :

Pubmed ID

2213394

DOI: Digital Object Identifier

10.1016/s0022-3476(05)80706-1

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.